ZEALAND PHARMA A/S — Credit Rating and Financial Key Figures

ZEALAND PHARMA A/S (CVR number: 20045078K) is a company from GLADSAXE. The company reported a net sales of 9214.9 mDKK in 2025, demonstrating a growth of 14598.9 % compared to the previous year. The operating profit percentage was at 75.5 % (EBIT: 6959.4 mDKK), while net earnings were 6455 mDKK. The profitability of the company measured by Return on Assets (ROA) was 57.6 %, which can be considered excellent and Return on Equity (ROE) was 55.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 93 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. ZEALAND PHARMA A/S's liquidity measured by quick ratio was 23.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.